CLT-005

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameCLT-005

Drug Alias NameSTAT-3 Inhibitor (Charlesson)CLT-005CTL-005-NP

ClassificationSmall molecules

Mechanisms of ActionVascular endothelial growth factor A modulatorsSignal transducer and activator of transcription 3 inhibitorsAngiogenesis inhibitors

TargetsVascular endothelial growth factor ASignal transducer and activator of transcription 3

Therapy Area/IndicationsDiabetic macular oedemaAngiogenesis disorderInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCharlesson

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCharlesson

Active IndicationsN/A

Inactive IndicationsDiabetic macular oedemaAngiogenesis disorderInflammation

Other Information

ATC CodeN/A